Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study

The emergence of new therapies for the treatment of rheumatoid arthritis (RA), the paucity of head-to-head studies, and the heterogeneous nature of responses to current biologics highlight the need for the identification of prognostic factors for treatment response and retention in clinical practice...

Full description

Bibliographic Details

Main Authors:	Nüßlein, Hubert G. (Author) , Lorenz, Hanns-Martin (Author)
Format:	Article (Journal)
Language:	English
Published:	30 July 2015
In:	BMC musculoskeletal disorders Year: 2015, Volume: 16
ISSN:	1471-2474
DOI:	10.1186/s12891-015-0636-9
Online Access:	Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12891-015-0636-9
Author Notes:	Hubert G. Nüßlein, Rieke Alten, Mauro Galeazzi, Hanns-Martin Lorenz, Michael T. Nurmohamed, William G. Bensen, Gerd R. Burmester, Hans-Hartmut Peter, Karel Pavelka, Melanie Chartier, Coralie Poncet, Christiane Rauch, Manuela Le Bars